Wells Fargo
BMEZ icon

Wells Fargo’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Wells Fargo’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
780,232
+1,445
+0.2% +$20.8K ﹤0.01% 2047
2026
Q1 		$11.2M Buy
778,787
+67,399
+9% +$1M ﹤0.01% 1947
2025
Q4 		$10.7M Sell
711,388
-29,382
-4% -$441K ﹤0.01% 1973
2025
Q3 		$10.7M Buy
740,770
+64,898
+10% +$922K ﹤0.01% 1945
2025
Q2 		$9.64M Buy
675,872
+28,237
+4% +$404K ﹤0.01% 1945
2025
Q1 		$9.65M Sell
647,635
-188,553
-23% -$2.95M ﹤0.01% 1877
2024
Q4 		$12M Sell
836,188
-73,004
-8% -$1.13M ﹤0.01% 1714
2024
Q3 		$14.4M Buy
909,192
+181,624
+25% +$2.86M ﹤0.01% 1544
2024
Q2 		$11.2M Sell
727,568
-35,029
-5% -$531K ﹤0.01% 1630
2024
Q1 		$12.5M Sell
762,597
-40,809
-5% -$643K ﹤0.01% 1574
2023
Q4 		$11.8M Sell
803,406
-273,197
-25% -$3.81M ﹤0.01% 1569
2023
Q3 		$15.5M Buy
1,076,603
+40,451
+4% +$631K ﹤0.01% 1257
2023
Q2 		$17M Sell
1,036,152
-12,684
-1% -$207K ﹤0.01% 1241
2023
Q1 		$17.5M Buy
1,048,836
+61,352
+6% +$988K 0.01% 1215
2022
Q4 		$15.2M Sell
987,484
-456,771
-32% -$7.07M ﹤0.01% 1279
2022
Q3 		$21.6M Buy
1,444,255
+118,842
+9% +$1.97M 0.01% 1030
2022
Q2 		$21.8M Buy
1,325,413
+48,927
+4% +$839K 0.01% 1091
2022
Q1 		$25.6M Buy
1,276,486
+1,939
+0.2% +$40.3K 0.01% 1151
2021
Q4 		$32.3M Buy
1,274,547
+105,383
+9% +$2.72M 0.01% 1021
2021
Q3 		$31.5M Buy
1,169,164
+62,065
+6% +$1.78M 0.01% 1342
2021
Q2 		$32M Buy
1,107,099
+9,815
+0.9% +$272K 0.01% 1359
2021
Q1 		$28.9M Buy
1,097,284
+306,316
+39% +$8.69M 0.01% 1388
2020
Q4 		$22.7M Buy
790,968
+213,606
+37% +$5.68M 0.01% 1471
2020
Q3 		$13.8M Buy
577,362
+333,497
+137% +$7.69M ﹤0.01% 1670
2020
Q2 		$5.1M Buy
243,865
+103,990
+74% +$2.05M ﹤0.01% 2444
2020
Q1 		$2.5M Buy
+139,875
New +$2.7M ﹤0.01% 2810

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

Wells Fargo's BMEZ Position: Q2 2026 in Review

Wells Fargo increased its BlackRock Health Sciences Trust II (BMEZ) stake by 0.19% in Q2 2026, buying an estimated $20.8K and bringing the position to 780,232 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2047.

Wells Fargo first reported a position in BMEZ in Q1 2020 and has held it in 26 quarters since. The position peaked at $32.3M in Q4 2021. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Wells Fargo held 780,232 shares of BlackRock Health Sciences Trust II worth $12M as of Q2 2026.
  • Wells Fargo bought 1,445 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $20.8K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2047 holding.
  • Wells Fargo first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and has held it in 26 quarters since.
  • Wells Fargo's BlackRock Health Sciences Trust II position peaked at $32.3M in Q4 2021.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.